These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1994656)

  • 1. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group.
    Boden WE; Krone RJ; Kleiger RE; Oakes D; Greenberg H; Dwyer EJ; Miller JP; Abrams J; Coromilas J; Goldstein R
    Am J Cardiol; 1991 Feb; 67(5):335-42. PubMed ID: 1994656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group.
    Boden WE; Scheldewaert R; Walters EG; Whitehead A; Coltart DJ; Santoni JP; Belgrave G; Starkey IR
    Am J Cardiol; 1995 Jun; 75(16):1120-3. PubMed ID: 7762497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.
    Wong SC; Greenberg H; Hager WD; Dwyer EM
    J Am Coll Cardiol; 1992 Jun; 19(7):1421-5. PubMed ID: 1593034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction.
    Boden WE; Kleiger RE; Schechtman KB; Capone RJ; Schwartz DJ; Gibson RS
    Am J Cardiol; 1988 Nov; 62(16):1000-4. PubMed ID: 2973215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am Heart J; 1991 Dec; 122(6):1548-53. PubMed ID: 1957749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of first myocardial infarction type (Q wave versus non-Q wave) and Q wave location. The Multicenter Diltiazem Post-Infarction Research Group.
    Benhorin J; Moss AJ; Oakes D; Marcus F; Greenberg H; Dwyer EM; Algeo S; Hahn E
    J Am Coll Cardiol; 1990 May; 15(6):1201-7. PubMed ID: 2184180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
    Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
    N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
    Haim M; Hod H; Reisin L; Kornowski R; Reicher-Reiss H; Goldbourt U; Boyko V; Behar S
    Am J Cardiol; 1997 Mar; 79(6):717-21. PubMed ID: 9070547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and significance of late evolution of Q waves in patients with initial non-Q-wave acute myocardial infarction. Diltiazem Reinfarction Study Group.
    Kleiger RE; Boden WE; Schechtman KB; Gibson RS; Schwartz DJ; Geiger BJ; Capone RJ; Roberts R
    Am J Cardiol; 1990 Jan; 65(1):23-7. PubMed ID: 2403730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Moss AJ; Oakes D; Rubison M; McDermott M; Carleen E; Eberly S; Brown M
    Am J Cardiol; 1991 Aug; 68(5):429-33. PubMed ID: 1872266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between diltiazem and left ventricular function after myocardial infarction. Multicenter Diltiazem Post-Infarction Research Group.
    Moss AJ; Oakes D; Benhorin J; Carleen E
    Circulation; 1989 Dec; 80(6 Suppl):IV102-6. PubMed ID: 2688978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial.
    Théroux P; Grégoire J; Chin C; Pelletier G; de Guise P; Juneau M
    J Am Coll Cardiol; 1998 Sep; 32(3):620-8. PubMed ID: 9741502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of non-Q-wave myocardial infarction: role of diltiazem versus beta-blocker therapy.
    Boden WE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S55-60. PubMed ID: 1707117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis within one year of first acute myocardial infarction: comparison between non-Q and Q wave myocardial infarction.
    Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
    Rev Port Cardiol; 2000 Dec; 19(12):1223-38. PubMed ID: 11220119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depression.
    Boden WE; Kleiger RE; Gibson RS; Schwartz DJ; Schechtman KB; Capone RJ; Roberts R
    Am J Cardiol; 1987 Apr; 59(8):782-7. PubMed ID: 3825938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q-wave myocardial infarction: results from the Multicenter Diltiazem Reinfarction Study.
    Gibson RS; Young PM; Boden WE; Schechtman K; Roberts R
    Am J Cardiol; 1987 Aug; 60(4):203-9. PubMed ID: 3303886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.